SCHEDULE: Nantahala Capital Reduces DarioHealth Stake Below 5%

Nantahala Capital Partners Limited Partnership has amended its Schedule 13G filing, reporting a beneficial ownership of 4.5912% in DarioHealth Corp., down from a previous stake above 5%.

Summary

• Nantahala Capital Partners Limited Partnership filed an Amendment No. 1 to its Schedule 13G regarding its holdings in DarioHealth Corp.
• The filing reports beneficial ownership of 316,497 shares of DarioHealth Corp. Common Stock.
• This represents 4.5912% of the total shares outstanding, based on 6,768,184 shares outstanding as of October 29, 2025.
• Nantahala Capital Partners now holds less than 5% of the class, indicating a reduction in its previous stake.
• The reporting person has shared voting and shared dispositive power over all 316,497 beneficially owned shares.

Sentiment

Score: 3

Explanation: The filing indicates a reduction in a significant institutional investor's stake below the 5% threshold, which is generally viewed negatively by the market as it suggests a decrease in conviction or a reallocation of capital.

Negatives

• Nantahala Capital Partners Limited Partnership has reduced its beneficial ownership in DarioHealth Corp. to below 5%.
• This reduction suggests a potential decrease in conviction or a reallocation of capital by a significant institutional investor.

Risks

• The reduction in institutional ownership by Nantahala Capital Partners could signal a perceived increase in risk or a less favorable outlook for DarioHealth Corp. by this investor.
• A decrease in institutional holdings can sometimes lead to negative market sentiment and downward pressure on the stock price.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May react negatively to the news of a significant institutional investor reducing its stake, potentially leading to downward pressure on the stock price.
• Company Management: Could face questions regarding the reasons for the institutional investor's reduced position.

Key Dates

Recommendation

Nantahala Capital Partners, a significant institutional investor, has reduced its stake in DarioHealth Corp. to below 5%. This move often signals a lack of confidence or a strategic reallocation of capital by a sophisticated investor, which could precede further downward pressure on the stock price. Investors may consider selling to mitigate potential losses.

Keywords

DarioHealth Corp., Nantahala Capital Partners, Schedule 13G, Beneficial Ownership, Institutional Investor, Stock Ownership, DRNA, SEC Filing, Equity Stake